Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M TEMKIN

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 8, 2023
Structural Sexism and Cancer Care: The Effects on the Patient and OncologistBridget P Keenan, Elizabeth Barr, Elizabeth Gleeson, et al.
American Journal of Clinical Oncology|February 7, 2007
Is body mass index an independent risk factor of survival among patients with endometrial cancer?Sarah M Temkin, John C Pezzullo, Mira Hellmann, et al.
Gynecologic Oncology|November 24, 2011
Have racial disparities in ovarian cancer increased over time? An analysis of SEER dataMishka Terplan, Nicholas Schluterman, Erica J McNamara, et al.
American Journal of Perinatology|May 21, 2005
Thrombotic thrombocytopenic purpura in a patient with acquired immunodeficiency syndrome at 28 weeks gestationDavid M Sherer, Jasotha Sanmugarajah, Mudar Dalloul, et al.
Gynecologic Oncology|March 17, 2023
What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black womenAnn Oluloro, Sarah M Temkin, Jonathan Jackson, et al.
Gynecologic Oncology|December 21, 2010
The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinomaErin A Bishop, Ernst R Lengyel, S Diane Yamada, et al.
Gynecologic Oncology|October 5, 2016
The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignanciesGrace Mishkin, Lori M Minasian, Elise C Kohn, et al.
Kardiologiia|October 1, 1980
[Experience with the clinical study of cordaron]E Sh Khalfen, I L Shvarts, Iu N Shigin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survivalSarah M Temkin, Eric A Miller, Goli Samimi, et al.
International Journal of Environmental Research and Public Health|March 8, 2020
Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl SubstancesAlexis M Temkin, Barbara A Hocevar, David Q Andrews, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 8, 2023
Structural Sexism and Cancer Care: The Effects on the Patient and OncologistBridget P Keenan, Elizabeth Barr, Elizabeth Gleeson, et al.
American Journal of Clinical Oncology|February 7, 2007
Is body mass index an independent risk factor of survival among patients with endometrial cancer?Sarah M Temkin, John C Pezzullo, Mira Hellmann, et al.
Gynecologic Oncology|November 24, 2011
Have racial disparities in ovarian cancer increased over time? An analysis of SEER dataMishka Terplan, Nicholas Schluterman, Erica J McNamara, et al.
American Journal of Perinatology|May 21, 2005
Thrombotic thrombocytopenic purpura in a patient with acquired immunodeficiency syndrome at 28 weeks gestationDavid M Sherer, Jasotha Sanmugarajah, Mudar Dalloul, et al.
Gynecologic Oncology|March 17, 2023
What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black womenAnn Oluloro, Sarah M Temkin, Jonathan Jackson, et al.
Gynecologic Oncology|December 21, 2010
The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinomaErin A Bishop, Ernst R Lengyel, S Diane Yamada, et al.
Gynecologic Oncology|October 5, 2016
The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignanciesGrace Mishkin, Lori M Minasian, Elise C Kohn, et al.
Kardiologiia|October 1, 1980
[Experience with the clinical study of cordaron]E Sh Khalfen, I L Shvarts, Iu N Shigin, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survivalSarah M Temkin, Eric A Miller, Goli Samimi, et al.
International Journal of Environmental Research and Public Health|March 8, 2020
Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl SubstancesAlexis M Temkin, Barbara A Hocevar, David Q Andrews, et al.
Pageof 12